Presidential Symposium 1
Invited discussant LBA1
Date
08 Oct 2016Session
Presidential Symposium 1Presenters
Stephen JohnstonAuthors
S. JohnstonAuthor affiliations
- Medical Oncology, Royal Marsden Hospital NHS Foundation Trust, London/GB
Resources
Login to access the resources on OncologyPRO.
If you do not have an ESMO account, please create one for free.
Resources from the same session
3552 - First-line ribociclib + letrozole for postmenopausal women with hormone receptor-positive (HR+), HER2-negative (HER2–), advanced breast cancer (ABC)
Presenter: Gabriel Hortobagyi
Session: Presidential Symposium 1
Resources:
Abstract
Slides
3070 - Ipilimumab (IPI) vs placebo (PBO) after complete resection of stage III melanoma: final overall survival results from the EORTC 18071 randomized, double-blind, phase 3 trial
Presenter: Alexander Eggermont
Session: Presidential Symposium 1
Resources:
Abstract
Slides
Invited discussant LBA2
Presenter: Olivier Michielin
Session: Presidential Symposium 1
Resources:
Slides
3367 - A randomized, double-blind phase 3 trial of maintenance therapy with niraparib vs placebo in patients with platinum-sensitive recurrent ovarian cancer (ENGOT-OV16/NOVA trial)
Presenter: Mansoor Raza Mirza
Session: Presidential Symposium 1
Resources:
Abstract
Slides
Invited discussant LBA3
Presenter: Sandro Pignata
Session: Presidential Symposium 1
Resources:
Slides